ProfileGDS5678 / 1445326_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 8% 8% 8% 7% 8% 10% 9% 11% 10% 8% 8% 8% 8% 8% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.205428
GSM967853U87-EV human glioblastoma xenograft - Control 22.190738
GSM967854U87-EV human glioblastoma xenograft - Control 32.181228
GSM967855U87-EV human glioblastoma xenograft - Control 42.108937
GSM967856U87-EV human glioblastoma xenograft - Control 52.135228
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.2878810
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.234259
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.2441611
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2268210
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.169668
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.175098
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.165828
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.171818
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.16998